Are These Penny Stocks on Your Watchlist This Coming Week?
There are a number of ways to find penny stocks that may be worth buying. When looking for penny stocks to buy, understanding exactly what is going on in the stock market is crucial. Because penny stocks are so speculative, they tend to move frequently with any news, announcements, or press releases. For that reason, it is crucial to be up to date on all the latest news surrounding a company before investing in its penny stock.
When it comes to buying small caps, there are a few specific strategies you can use to find penny stocks that may be worth buying. But before that, investors need to have a solid understanding of their own investing strategy and risk tolerance. This will allow you to weed out any penny stocks that don’t fit your investing philosophy. With penny stocks, risk is an inherent factor to consider. That is why many conservative investors tend to avoid them.
But, for those who are willing to take on a little more risk, penny stocks can offer the potential for huge rewards. And with so many different companies to choose from, there are penny stocks for every type of investor. So, always make sure you understand exactly what a company does, what its volatility is, and what its fundamentals look like. With this in mind, let’s take a look at three penny stocks to add to your watchlist right now.
3 Penny Stocks to Add to Your Watchlist This Week
- Clarus Therapeutics Holdings Inc. (NASDAQ: CRXT)
- Borqs Technologies Inc. (NASDAQ: BRQS)
- Petros Pharmaceuticals Inc. (NASDAQ: PTPI)
Clarus Therapeutics Holdings Inc. (NASDAQ: CRXT)
After a 180% gain in the period of April 19th to April 20th, shares of CRXT stock have been on many investors radars. Despite a 20% drop on April 22nd, it’s clear that there is a sizable amount of bullish sentiment to go around. The main reason for this comes as the company announced new data for JATENZO as well as its quarterly results a few weeks earlier.
As for the first, CRXT announced that JATENZO, which is the first FDA approved oral soft gel for testosterone therapy in adult men. In its Q4 and full year results, the company announced net revenue increases of 119% or $14 million YoY. And, it announced that Q4 net revenue pushed up by more than 88% YoY, which is no small feat.
“Clarus delivered solid growth in net revenue as a new public company driven by continued demand for JATENZO. We also significantly expanded payer access coverage for JATENZO as payers recognized its value and innovation for treatment of appropriate hypogonadal men. In February, we launched our new online patient portal, partnering with Vault Health and AssistRx, leaders in providing healthcare services to patients.”CEO of Clarus, Dr. Robert Dudley
With its exciting gains in the past few weeks, Clarus Therapeutics remains an interesting penny stock to watch. Whether it’s worth adding to your list of penny stocks to buy however, is up to you.
Borqs Technologies Inc. (NASDAQ: BRQS)
Another penny stock that has seen substantial gains recently is BRQS stock. In the past five day period, shares of BRQS stock have climbed by more than 55%. This is no small feat and shows exactly how much bullish sentiment there is around Borqs Technologies.
The most recent news from the company came on April 14th when it announced that it successfully purchased a 5G license with Qualcomm. This license will allow it to produce 5G products based on Qualcomm’s technology. And because 5G has become so popular in the past year or so, there is a sizable amount of opportunity in this market.
If you’re not familiar, Borqs Technology is a leader when it comes to software and products for IoT. This includes a library of chipset software, android enhancements, and 5G products for phones and hotspots. In addition, the company recently acquired a controlling interest in a solar energy systems company domestically. So, with this in mind, do you think BRQS stock is worth adding to your penny stocks watch list or not?
Petros Pharmaceuticals Inc. (NASDAQ: PTPI)
With a five day gain of over 14%, Petros Pharmaceuticals has continued to garner attention over the last few weeks. And despite a one year drop of more than 55%, there has been a sizable recent bullish turnaround with PTPI stock. With an over 40% surge only a few days ago, the main news with PTPI comes as it announced positive results for its OTC erectile dysfunction drug known as STENDRA.
“The results of this label comprehension study help us to continue to solidify our plans to apply to the FDA to help expand access for STENDRA beyond the prescription model, and, if approved by the FDA, to make STENDRA potentially the first prescription-grade ED medication to become available over-the-counter in the United States.”The CCO of Petros, Fady Boctor
If it is able to gain OTC status for this compound, there’s no telling what potential Petros could have moving forward. Considering that, do you think it’s worth buying next month?
Are Penny Stocks Worth Buying?
Finding the best penny stocks to buy can be a daunting task for any investor, especially those new to the stock market. However, with a little research and due diligence, it is possible to find penny stocks that have the potential to generate profits. factors, including the company’s financials, its business.
When looking for penny stocks to buy, it is important to consider a number of factors. This includes looking at the company’s balance sheet, income statement, and cash flow statement. By doing this, you can get a better idea of the company’s overall financial health. So, with all of this in mind, do you think that penny stocks are worth buying or not?